HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas E Merchant Selected Research

6'-N-methylsisomicin (G 52)

1/2022Do Anxiety and Mood Vary among Disparate Sleep Profiles in Youth with Craniopharyngioma? A Latent Profile Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas E Merchant Research Topics

Disease

103Neoplasms (Cancer)
12/2022 - 01/2002
39Brain Neoplasms (Brain Tumor)
07/2022 - 08/2002
36Ependymoma
01/2022 - 02/2002
32Craniopharyngioma (Craniopharyngiomas)
12/2022 - 07/2002
29Glioma (Gliomas)
01/2022 - 02/2006
24Medulloblastoma
01/2022 - 08/2005
10Retinoblastoma (Glioblastoma, Retinal)
11/2022 - 05/2002
9Hearing Loss (Hearing Impairment)
01/2020 - 11/2008
9Hydrocephalus (Hydrocephaly)
12/2019 - 02/2003
8Diffuse Intrinsic Pontine Glioma
01/2021 - 11/2010
8Sarcoma (Soft Tissue Sarcoma)
01/2012 - 08/2002
5Hypothyroidism
12/2022 - 03/2008
5Neoplasm Metastasis (Metastasis)
05/2022 - 06/2003
4Central Nervous System Neoplasms
12/2020 - 09/2009
4Precocious Puberty
12/2020 - 08/2009
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 06/2015
4Hodgkin Disease (Hodgkin's Disease)
06/2013 - 06/2004
4Familial ependymoma
07/2010 - 05/2002
3Diabetes Insipidus
12/2022 - 02/2006
3Neuroblastoma
05/2022 - 03/2010
3Cysts
01/2022 - 02/2006
3Adrenocorticotropic hormone deficiency
12/2020 - 03/2008
3Sensorineural Hearing Loss
09/2018 - 11/2008
3Infratentorial Neoplasms (Posterior Fossa Tumors)
01/2018 - 05/2009
3Disease Progression
09/2017 - 03/2013
3Obesity
03/2016 - 02/2003
3Necrosis
08/2012 - 02/2002
3Rhabdoid Tumor (Rhabdoid Tumors)
04/2012 - 03/2005
3Primitive Neuroectodermal Tumors (PNET)
04/2012 - 04/2008
2Choroid Plexus Carcinoma
01/2021 - 01/2018
2Adrenal Insufficiency (Adrenal Gland Hypofunction)
10/2020 - 01/2019
2Neurologic Manifestations (Neurological Manifestations)
03/2020 - 12/2019
2Brain Injuries (Brain Injury)
01/2020 - 03/2010
2Pinealoma (Pineoblastoma)
01/2020 - 01/2020
2Rhabdomyosarcoma
01/2020 - 12/2018
2Cognitive Dysfunction
01/2019 - 11/2014
2Disorders of Excessive Somnolence (Hypersomnia)
01/2018 - 07/2016
2Deafness (Deaf Mutism)
11/2015 - 06/2014
2Neuroepithelial Neoplasms (Gliomatosis Cerebri)
01/2014 - 02/2006
2Ototoxicity
04/2012 - 08/2008
2Diarrhea
11/2010 - 01/2009
2Supratentorial Neoplasms
11/2009 - 05/2009
2Congenital Abnormalities (Deformity)
07/2009 - 08/2004

Drug/Important Bio-Agent (IBA)

10Growth Hormone (Somatotropin)IBA
12/2020 - 07/2009
10Vincristine (Oncovin)FDA LinkGeneric
11/2012 - 05/2003
8dipinacoline glutamateIBA
01/2021 - 06/2013
7Protons (Proton)IBA
07/2022 - 07/2008
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2012 - 11/2004
6Biological ProductsIBA
01/2021 - 03/2006
5Biomarkers (Surrogate Marker)IBA
11/2021 - 02/2002
5Cisplatin (Platino)FDA LinkGeneric
06/2014 - 03/2008
4Hormones (Hormone)IBA
12/2022 - 02/2002
4Carboplatin (JM8)FDA LinkGeneric
11/2022 - 05/2003
4RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020
4Pharmaceutical PreparationsIBA
01/2021 - 09/2005
4Alkylating AgentsIBA
12/2019 - 11/2004
4Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2018 - 01/2009
3Dihydrotachysterol (AT 10)IBA
12/2022 - 11/2004
3Etoposide (VP 16)FDA LinkGeneric
11/2022 - 05/2003
3Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2009
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2012
36-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
12/2020 - 03/2016
3Levodopa (L Dopa)FDA LinkGeneric
11/2012 - 04/2002
3Arginine (L-Arginine)FDA Link
11/2012 - 04/2002
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2011 - 05/2005
2cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2021 - 01/2018
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2009
2GonadotropinsIBA
12/2020 - 03/2016
2Adrenocorticotropic Hormone (ACTH)FDA Link
12/2019 - 02/2011
2Glucose (Dextrose)FDA LinkGeneric
11/2019 - 11/2015
2Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 11/2004
2GlucocorticoidsIBA
01/2019 - 02/2003
2PlatinumIBA
11/2015 - 11/2008
2Amifostine (Ethyol)FDA LinkGeneric
06/2014 - 08/2008
2ErbB Receptors (EGF Receptor)IBA
01/2014 - 11/2010
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2014 - 11/2010
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2013 - 11/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2013 - 05/2009
2vandetanib (ZD6474)IBA
06/2013 - 11/2010
2EnzymesIBA
08/2012 - 01/2009
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2007 - 02/2002
2AnthracyclinesIBA
08/2007 - 11/2004

Therapy/Procedure

157Radiotherapy
12/2022 - 02/2002
60Therapeutics
11/2022 - 01/2002
53Drug Therapy (Chemotherapy)
11/2022 - 05/2002
20Craniospinal Irradiation
10/2020 - 08/2005
18Proton Therapy
01/2022 - 07/2009
13Aftercare (After-Treatment)
12/2022 - 05/2006
5Conformal Radiotherapy
03/2020 - 08/2006
5Re-Irradiation
01/2020 - 05/2008
5Brachytherapy
06/2018 - 08/2004
4Operative Surgical Procedures
05/2015 - 02/2006
3Maintenance Chemotherapy
05/2022 - 09/2012
3Hearing Aids (Hearing Aid)
11/2015 - 08/2008
3Combined Modality Therapy
11/2005 - 06/2004
2Induction Chemotherapy
05/2022 - 09/2012
2Consolidation Chemotherapy
10/2019 - 06/2003
2Anesthesia
01/2019 - 03/2011
2Ventriculoperitoneal Shunt
11/2015 - 05/2009
2Adjuvant Chemotherapy
01/2015 - 08/2014